In response to What is the optimal perioperative management of antiplatelet therapy?
نویسندگان
چکیده
BACKGROUND A significant proportion of patients undergoing otolaryngological surgery take antiplatelet therapy for a variety of conditions, including coronary artery disease and angina; following cardiac procedures, stroke, or transient ischemic attacks; and peripheral vascular disease. However, continuation of antiplatelet therapy may lead to increased risk of bleeding, whereas discontinuation could cause cardiovascular complications.
منابع مشابه
Perioperative management of neurosurgical patients receiving chronic anticoagulation therapy
In all neurosurgical cases associated with anticoagulation/antiplatelet therapy, perioperative antithrombotic management of patients is complicated due to increased risks of intraand/or postoperative bleeding or thromboembolic complications. The potential risk of thrombosis may increase when anticoagulation/antiplatelet therapy is stopped perioperatively. On the other hand, perioperative hemorr...
متن کاملIs Aspirin Still the Cornerstone of Antiplatelet Therapy in Patients With Coronary Artery Disease? An Historical and Practical Narrative Review
Aspirin is an irreversible and non-selective inhibitor of cyclo-oxygenase. It represents the cornerstone of antiplatelet therapy and is used in secondary prevention of cardiovascular disease. Disagreement over the optimal maintenance dosage still exists; in America and Europe the most used doses of aspirin are 81 mg and 100 mg daily, respectively. There is also debate on the formulation and rou...
متن کاملCURRENT GUIDELINES: WHAT IS THE MINIMUM DURATION OF DAPT AFTER PCI? With Bare-Metal Stents
T he need for antithrombotic therapy after percutaneous coronary intervention (PCI) has been a troublesome issue for physicians for more than 20 years. With the advent of drug-eluting stents (DES), a minimum of 12 months of dual-antiplatelet therapy (DAPT) has become the norm. However, evolving stent and drug technologies are now set to change this dogma. In this article, we focus on the periop...
متن کاملPerioperative management of antiplatelet therapy.
Worldwide, cardiovascular events represent the major cause of morbidity and mortality. A key role in the pathogenesis of these events is played by platelets. Interventional procedures, with placement of coronary and vascular stents, often represent the preferred therapeutic strategy. Antiplatelet medications are considered first-line therapy in preventing cardiovascular thrombotic events. A wid...
متن کاملPerioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies.
Optimal perioperative antiplatelet therapy in patients with coronary stents undergoing surgery still remains poorly defined and a matter of debate among cardiologists, surgeons and anaesthesiologists. Surgery represents one of the most common reasons for premature antiplatelet therapy discontinuation, which is associated with a significant increase in mortality and major adverse cardiac events,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Laryngoscope
دوره 126 9 شماره
صفحات -
تاریخ انتشار 2016